 |
市場調查報告書
商品編碼
1555671
340B 藥品價格管理系統（2024）：供應商是否在高能量市場中推動節省？340B Management Systems 2024 Are Vendors Driving Savings in a High-Energy Market? |
||||||
340B藥品價格管理方案是一個持續高能量的市場，對於被分析的醫療機構來說，由於尋求降低組織和病患的成本而成為首要問題。隨著藥品製造商的法規強化，並且未來法規有可能進一步加強，醫療保健組織繼續向 340B 價格管理供應商尋求工具和專業知識來駕馭這一領域。本報告分析並提供客戶對340B 藥品價格管理供應商的滿意度，各種類型客戶的使用情況、客戶節省和有效利用的趨勢、供應商支持的水準以及如何應對日益成長的挑戰等資訊。
目錄
高階主管洞察力
供應商見解
資料指標
A market with consistently high energy, 340B programs remain top of mind for eligible healthcare organizations as they try to drive cost savings for both their organization and their patients. With increasing drug manufacturer restrictions and the possibility of additional legislation down the road, organizations continue to look to their 340B management vendors for tools and expertise to help navigate this space. This report examines customer satisfaction with 340B management vendors by looking at factors such as use by different customer types, customer ability to find savings and get their money's worth, strength of vendor support, and vendor guidance in managing evolving challenges.
Table of Contents
2-Executive Insights
8-Vendor Insights
14-Data Index
